Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-05-14

FDA Approved: ZOLMITRIPTAN — Original Application (Glenmark Pharmaceuticals Inc.,USA)

View source ↗

Summary

FDA approved Glenmark's original ANDA for zolmitriptan tablets, providing a generic option for the treatment of acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

ORIG AP for ZOLMITRIPTAN (ZOLMITRIPTAN)